New therapeutic strategy improves survival for inoperable liver cancer patients

Data presented at the ASCO congress shows that a new therapeutic strategy significantly improves the survival of patients initially deemed inoperable for liver cancer, with nearly one in three patients remaining alive and disease-free two years post-treatment.